Martin B. Leon, MD

Expertise in: 
Interventional Cardiology
Board Certifications: 
Internal Medicine, Cardiovascular Disease
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Interventional Cardiology, Interventional Cardiology, Cardiac Catheterization, Angioplasty, Percutaneous Transluminal, TAVR (Transcatheter Aortic Valve Replacement), Valvular Heart Disease, Clinical Research Trials

Academic Appointments

  • Professor of Medicine at NewYork-Presbyterian/Columbia University Medical Center

Martin B. Leon, MD – Interventional Cardiologist

Martin B. Leon, MD is Professor of Medicine at Columbia University Medical Center (CUMC). Dr. Leon is also Director of the Center for Interventional Vascular Therapy (CIVT), Director of the Cardiac Catheterization Laboratories, and on the Executive Board of the Columbia NewYork-Presbyterian Heart Valve Center. He continues as a practicing Interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation.

Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies.

He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.

Dr. Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York. Prior to that, he was Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. Earlier in his career, he served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.

Dr. Leon completed a fellowship in Cardiology at the Yale-New Haven Hospital. He completed medical school at the Yale School of Medicine, and his internship and residency in internal medicine at the Yale-New Haven Hospital.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Lawrence Hospital

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-7060

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Yale University School of Medicine, New Haven, CT
  • Internship: Yale-New Haven Hospital
  • Residency: Yale-New Haven Hospital
  • Fellowship: Yale-New Haven Hospital

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease
America's Top Doctor

Research

Grants

TRANSCATHETER MITRAL VALVE REPLACEMENT WITH THE MEDTRONIC INTREPID TMVR SYSTEM IN PATIENTS WITH SEVERE SYMPTOMATIC MITRAL REGURGITATION APOLLO TRIAL (P&S Industry Clinical Trial)

Jan 12 2018 - Jan 12 2023

WATCHMAN FOR PATIENTS WITH ATRIAL FIBRILATION UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (P&S Industry Clinical Trial)

Jan 9 2018 - Jan 9 2023

THE MITRAL TRIAL - MITRAL IMPLANTATION OF TRANSCATHETER VALVES IN NATIVE MITRAL STENOSIS (P&S Industry Clinical Trial)

Sep 30 2015 - Sep 30 2020

CMR MYOCARDIAL TISSUE BASED ON PREDICTION OF ISCHEMIC MR REVASCULARIZATION RESPONSE (Federal Gov)

Apr 1 2016 - Jun 30 2020

EARLY FEASIBILITY STUDY OF THE NEOVASC TIARA MITRAL TRANSCATHETER HEART VALVE WITH THE TIARA TRANSAPICAL DELIVERY SYSTEM (TIARA-I) (P&S Industry Clinical Trial)

Dec 29 2014 - Dec 29 2019

CMR MYOCARDIAL TISSUE BASED ON PREDICTION OF ISCHEMIC MR REVASCULARIZATION RESPONSE (Federal Gov)

Apr 1 2016 - Jun 30 2019

PHILIPS CLARITY PROJECT EXHIBIT B-14 (P&S Industry Clinical Trial)

Mar 4 2014 - Mar 4 2019

CMR MYOCARDIAL TISSUE BASED ON PREDICTION OF ISCHEMIC MR REVASCULARIZATION RESPONSE (Federal Gov)

Apr 1 2016 - Jun 30 2017

CMR MYOCARDIAL TISSUE BASED ON PREDICTION OF ISCHEMIC MR REVASCULARIZATION RESPONSE (Federal Gov)

Apr 1 2016 - Jun 30 2016

THE PARTNER TRIAL: PLACEMENT OF AORTIC TRANSCATHETER VALVES TRIAL (P&S Industry Clinical Trial)

May 29 2007 - Nov 30 2012

ZOMAXX II TRIAL RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THE ZOMAXX DES SYSTEM COMPARED TO (P&S Industry Clinical Trial)

Jan 14 2005 - Jul 31 2012